Kymera Therapeutics Inc (KYMR)
SG&A Expense Growth
3.78%
Quarterly · Period ending:
KYMR SG&A Expense Growth
Latest reported3.78%period ending
Latest reported3.78%period ending
KYMR Quarterly SG&A Growth (QoQ) (0.00% → 3.78%)
Latest values, visible window
High-resolution chart · PNG
KYMR sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.7776% | |
| 20.1145% | |
| -2.2381% | |
| -1.7512% | |
| 8.4445% | |
| -0.3735% | |
| 5.6745% | |
| -11.0401% | |
| 20.8641% | |
| 1.0332% | |
| 0.7578% | |
| -0.0637% | |
| 12.4473% | |
| 7.9838% | |
| 10.2311% | |
| -4.306% | |
| 3.9582% | |
| -9.6167% | |
| 10.0591% | |
| 32.8559% | |
| 35.8775% | |
| 14.1836% | |
| -24.32% | |
| 86.7796% | |
| 43.0637% | |
| 1.1462% | |
| 68.5543% | |
| 0% |